Difference between revisions of "Konopleva M, et al. Cancer Discov. (2016) cited as Ref 627 in DOI: 10.1038/s41392-020-0110-5 (Q9890)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 6, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia (English) | ||
| Property / title: Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:05, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Konopleva M, et al. Cancer Discov. (2016) cited as Ref 627 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Konopleva M
0 references
2016
0 references
Cancer Discov.
0 references
6
0 references
Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia (English)
0 references
